Synonym: 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one
CAS Number: 599151-35-6
Empirical Formula (Hill Notation): C18H17NO4
Molecular Weight: 311.33
MDL Number: MFCD03632583
Linear Formula: C18H17NO4
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML0413-25MG.
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C18H17NO4/c1-2-21-15-6-4-3-5-11(15)12-8-18(20)19-14-9-17-16(7-13(12)14)22-10-23-17/h3-7,9,12H,2,8,10H2,1H3,(H,19,20) |
| InChI key |
YKSYGLXHLSPWLB-UHFFFAOYSA-N |
| Quality Level |
100  |
| SMILES string |
O=C1CC(C2=CC=CC=C2OCC)C3=CC4=C(OCO4)C=C3N1 |
| solubility |
DMSO: 10 mg/mL (clear solution) |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
FQI1 inhibits the DNA-binding activity of LSF, a ubiquitous transcription factor that is up regulated in many hepatocellular carcinomas (HCC). FQI1 inhibits LSF-dependent luciferase reporter expression, blocks proliferation in cancer cell lines, and induces apoptosis in liver cancer cells but is not toxic to primary hepatocytes. FQI1 also inhibits tumor growth in a mouse HCC xenograft model. |
| Biochem/physiol Actions: |
FQI1 is an inhibitor of transcription factor LSF. |
| Packaging: |
5, 25 mg in glass bottle |
| Hazard Codes |
T,N |
| Risk Statements |
25-50 |
| Safety Statements |
45-61 |
| RIDADR |
UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., |
| WGK Germany |
WGK 3 |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |